EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

The Safety, Efficacy, and Feasibility of Fecal Microbiota Transplantation in a Population With Bipolar Disorder During Depressive Episodes: A Pilot Parallel Arm Randomized Controlled Trial: Sécurité, efficacité et faisabilité de la transplantation de microbiote fécal chez une population atteinte de troubles bipolaires, au cours d’épisodes dépressifs : essai pilote contrôlé à répartition aléatoire et à groupes parallèles

Shahrokh Shekarriz, Simone N Vigod iD, Teresa Bianco, Asem Bala iD, Chenhui Hao, Johane P Allard, Susy Hota, Susan Poutanen, Michael G Surette, Valerie H Taylor iD

The Canadian Journal of Psychiatry · 2026

DOI: 10.1177/07067437261420877 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The Canadian Journal of Psychiatry, 2026. Verfasst von Shahrokh Shekarriz und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, McMaster University, Hamilton, Ontario, Canada. Hauptthemen laut MEDLINE: Fecal Microbiota Transplantation, Bipolar Disorder, Outcome Assessment, Health Care. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Stanley Medical Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The gut microbiome has been proposed as a potential modifiable target to treat mental illness. This double-blind randomized control trial investigated fecal microbiota transplant (FMT) in bipolar disorder (BD) to assess efficacy, safety, and feasibility. The primary outcome evaluated the effectiveness of standard approved therapy for BD depression + FMT in individuals not responding to standard treatment, measured by change in the Montgomery-Åsberg Depression Rating Scale (MADRS) score from baseline to week 24. Secondary outcomes included FMT's impact on anxiety, global function, side-effects, and safety. The feasibility of this novel intervention was also assessed. Microbial analysis utilized whole-genome shotgun metagenomic sequencing, comparing outcomes between allogenic (donor) and autologous (participants own) FMT.

Methods

A total of 35 participants (28 women and 7 men) with at least moderate depressive-phase BD (MADRS) were randomized to receive either allogenic FMT (n = 17) or autologous FMT (n = 18) via colonoscopy and were followed for 24 weeks.

Results

MADRS scores significantly improved from baseline to the last visit in both treatment arms. There was no significant difference between allogenic FMT (16.74-point improvement) and autologous FMT (15.4-point improvement) regarding clinical efficacy (t = −0.47, p-value = .64, 95% confidence interval [CI] = −7.3–4.6). Microbiota analysis showed that allogenic FMT let to a bacterial profile similar to the healthy donor and increased bacterial diversity at the 6-month mark, whereas those receiving autologous FMT did not. The intervention was well tolerated with no significant adverse events. Recruitment, randomization, and retention metrics support feasibility of a larger trial.

Conclusion

Feasibility and tolerability data indicate further investigation into microbial manipulation in BD is warranted. The absence of efficacy differences between the two types of FMT, despite microbial change, highlights the importance of a true placebo in future studies, as well as the importance of understanding exactly what bacteria are linked to improvements. ClinicalTrials.gov, NCT0327922 Plain Language Summary Title Results of a Double-Blind Randomized Control Trial Investigating Fecal Microbiota Transplant (FMT) as an Add-on Treatment for Depression in Bipolar Disorder and Analyzing Microbial Diversity Changes Over 24 Weeks

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fecal Microbiota TransplantationBipolar DisorderOutcome Assessment, Health CareHumansFemaleDouble-Blind MethodMalePilot ProjectsFeasibility StudiesAdultMiddle Aged

Stichwörter der Autor:innen

bipolar disorderfecal microbiota transplantationgut–brain axismicrobiome-based therapiespsychobiotics

Autor:innen und Institutionen

  • Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada.
  • Women's College Research Institute, Women's College Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Joint Department of Medical Imaging, Breast Division, Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada.
  • Department of Psychiatry, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

ORCID-Profile: Simone N Vigod, Asem Bala, Valerie H Taylor

Förderung

  • Stanley Medical Research Institute

Zitieren

APA

Shekarriz, S., Vigod, S. N., Bianco, T., Bala, A., Hao, C., Allard, J. P., Hota, S., Poutanen, S., Surette, M. G., & Taylor, V. H. (2026). The Safety, Efficacy, and Feasibility of Fecal Microbiota Transplantation in a Population With Bipolar Disorder During Depressive Episodes: A Pilot Parallel Arm Randomized Controlled Trial: Sécurité, efficacité et faisabilité de la transplantation de microbiote fécal chez une population atteinte de troubles bipolaires, au cours d’épisodes dépressifs : essai pilote contrôlé à répartition aléatoire et à groupes parallèles. The Canadian Journal of Psychiatry. https://doi.org/10.1177/07067437261420877

Vancouver

Shekarriz S, Vigod SN, Bianco T, Bala A, Hao C, Allard JP, et al. The Safety, Efficacy, and Feasibility of Fecal Microbiota Transplantation in a Population With Bipolar Disorder During Depressive Episodes: A Pilot Parallel Arm Randomized Controlled Trial: Sécurité, efficacité et faisabilité de la transplantation de microbiote fécal chez une population atteinte de troubles bipolaires, au cours d’épisodes dépressifs : essai pilote contrôlé à répartition aléatoire et à groupes parallèles. The Canadian Journal of Psychiatry. 2026. doi:10.1177/07067437261420877

BibTeX
@article{Shekarriz2026,
  author = {Shekarriz, Shahrokh and Vigod, Simone N and Bianco, Teresa and Bala, Asem and Hao, Chenhui and Allard, Johane P and Hota, Susy and Poutanen, Susan and Surette, Michael G and Taylor, Valerie H},
  title = {The Safety, Efficacy, and Feasibility of Fecal Microbiota Transplantation in a Population With Bipolar Disorder During Depressive Episodes: A Pilot Parallel Arm Randomized Controlled Trial: Sécurité, efficacité et faisabilité de la transplantation de microbiote fécal chez une population atteinte de troubles bipolaires, au cours d’épisodes dépressifs : essai pilote contrôlé à répartition aléatoire et à groupes parallèles},
  journal = {The Canadian Journal of Psychiatry},
  year = {2026},
  doi = {10.1177/07067437261420877}
}
Kostenlos starten →